Rallying to the Challenge 2024 - Day 1
Dr Laurie Sanders, Duke University

Dr Laurie Sanders, from Duke University, explores the potential of mitochondrial DNA damage as a biomarker for Parkinson’s. Laurie also provides insight into her team's development of the Mito DNADX assay, a tool designed to detect mitochondrial DNA damage, which could play a crucial role in evaluating the effectiveness of new treatments for Parkinson’s.

This talk was given as a part of the Rallying to the Challenge meeting, hosted by Cure Parkinson's and the Van Andel Institute in Grand Rapids, Michigan on September 23-24, 2024. Rallying to the Challenge is a meeting designed for and by people with Parkinson’s, advocates, and care partners to explore how the Parkinson’s community can impact and accelerate research. It is a part of the larger Grand Challenges in Parkinson's Disease meeting, an annual scientific symposium for Parkinson's research.